• Leptin (116-130), amide, mouse: Lab Workflow

  2026-09-24

  Use this amidated mouse leptin fragment to design focused metabolic and immunometabolic assays, with careful controls that distinguish fragment activity from full-length leptin biology. The workflow emphasizes fresh preparation, dose-finding, functional readouts, and the limits of borrowing experimental logic from a separate atrial-fibrillation study.

• CpAdhE Inhibition Reveals a Cryptosporidium Drug Target

  2026-09-24

  A 2024 study characterized the fermentative enzyme CpAdhE in Cryptosporidium parvum and identified antifungal imidazoles and unsaturated fatty acids as inhibitors in a biochemical screen. Three imidazoles also reduced parasite growth in vitro, supporting further investigation while leaving target engagement, selectivity, and in vivo efficacy to be established.

• SEMA3E Drives Beige Adipocyte Thermogenesis via β-Catenin

  2026-09-23

  A 2026 mouse study identifies SEMA3E as a regulator of beige adipocyte differentiation and thermogenesis, linking its effects to mitochondrial oxidative phosphorylation and β-catenin signaling. The combination of cell-based perturbations, adipose-tissue knockdown, and functional readouts supports a role for SEMA3E in cold- and agonist-induced thermogenic responses, while leaving important questions about pathway dynamics and applicability to humans.

• Rosiglitazone (Brl-49653) Adipogenesis Workflows

  2026-09-23

  Build reproducible PPARγ activation experiments with Rosiglitazone (Brl-49653), from DMSO stock preparation to adipocyte differentiation, glucose-handling assays, and mitochondrial readouts. The workflow also shows how pharmacological PPARγ stimulation can complement SEMA3E gain- and loss-of-function studies without conflating adipogenesis with thermogenesis.

• Protease Inhibitor Cocktail for Lipid Droplet Assays

  2026-09-22

  Protect DFCP1–ATGL interactions and other labile targets during cell and tissue extraction with a broad-spectrum, water-soluble inhibitor mixture. This practical guide covers 1X setup, EDTA-sensitive assays, Co-IP and kinase workflows, plus troubleshooting for lipid droplet research.

• ABT-737 and Mitochondrial RNA During Apoptosis

  2026-09-22

  ABT-737 is a selective BCL-2 protein inhibitor for studying mitochondrial apoptosis in cancer models. This article connects its BAK-dependent mechanism with super-resolution imaging of mitochondrial mRNA, offering a practical framework for resolving apoptotic signaling from mitochondrial RNA remodeling.

• Arachidonic Acid and Rapid Humoral Immunity

  2026-09-21

  The reference study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node ARA–PGI2–cAMP–PKA pathway that supports CD86 expression and activation-induced cytidine deaminase in B cells, offering a framework for studying dietary modulation of germinal-center responses.

• Benzyl-activated Streptavidin Magnetic Beads

  2026-09-21

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnetic capture of biotinylated proteins, peptides, antibodies, nucleic acids, and other compatible molecules from complex samples. They are not a general ligand for non-biotinylated analytes, and the supplied BSA- and sodium azide-containing formulation requires compatibility testing before sensitive enzymatic or live-cell workflows.

• PRKX–PD-L1 Stabilization in Gastric Cancer

  2026-09-20

  This study defines immunosuppressive and immune-activated gastric cancer microenvironment subtypes and identifies PRKX as a regulator of PD-L1 protein stability. Its findings connect PRKX-dependent phosphorylation to CD8+ T-cell exhaustion, anti-PD-1 resistance, biomarker development, and a potential siRNA combination strategy.

• Benzyl-activated Streptavidin Magnetic Beads Workflow

  2026-09-19

  Build faster, cleaner capture workflows for biotinylated proteins, nucleic acids, and assay reagents with magnetically separable Benzyl-activated Streptavidin Magnetic Beads. The workflow also shows how bead-based recovery can complement annexin-V studies of early cardiomyocyte death without confusing enrichment with in vivo imaging.

• Fluorescein Tyramide for Sensitive Brain Assays

  2026-09-18

  Fluorescein Tyramide converts weak enzyme-linked signals into bright, spatially deposited fluorescence for challenging IHC and ISH experiments. This guide shows how to apply it to low-abundance oxytocin-receptor studies, multiplexed circuit mapping, and carefully controlled flow-based assays.

• Morin as a Mechanistic Assay Bridge

  2026-09-18

  Morin is a multifunctional flavonoid for connecting oxidative stress, mitochondrial metabolism, inflammation, and metal-ion sensing in research assays. This article explains how to use Morin thoughtfully while interpreting a neuroleptic malignant syndrome case as a model of phenotype-first experimental reasoning.

• Acridine Orange hydrochloride: Practical QC Guide

  2026-09-17

  Acridine Orange hydrochloride provides membrane-permeable, differential nucleic acid fluorescence for workflows such as cell cycle analysis, apoptosis detection, and flow cytometric DNA/RNA assessment. This dossier-based guide explains handling and QC while defining limits: it is intended for nucleic acid staining, not non-nucleic-acid targets, and freshly prepared solutions should be used promptly rather than stored long term.

• QPRT, P2Y11 Signaling, and Breast Cancer Invasion

  2026-09-17

  The reference study links elevated quinolinate phosphoribosyltransferase (QPRT) with breast cancer cell migration and invasion, identifying myosin light-chain phosphorylation as a functional downstream event. Its combination of genetic manipulation and pharmacological pathway dissection suggests that purinergic signaling may connect NAD+ metabolism to Rho/ROCK, PLC, and MLCK-dependent cytoskeletal remodeling.

• Eudragit S100-Coated LNPs for Oral RNA Delivery

  2026-09-16

  The reference study develops a pH-responsive Eudragit S 100 coating that protects lipid nanoparticles during gastric exposure while enabling particle recovery and RNA transfection under intestinal conditions. Its formulation and simulated-fluid experiments provide a useful proof of concept for improving the oral stability of LNP-based RNA systems, although in vivo delivery remains to be established.

8605 records 1/574 page Next 12345 下5页 Last page